Palo Santo Fund

company

About

Palo Santo Fund is an investment fund that invests in psychedelic and healthcare industry.

  • 1 - 10

Highlights

Details

Industries
Biopharma,Biotechnology,Health Care,Pharmaceutical,Therapeutics,Wellness
Founded date
Jan 1, 2020
Number Of Employee
1 - 10
Operating Status
Active
Investor Type
Venture Capital

The future of mental wellness is being built today. Through its diversified investment fund, Palo Santo is positioned to increase the supply of clinically effective, affordable, and accessible mental health and addiction treatment solutions needed in today’s world.

Supported by a rapidly growing body of evidence and strong FDA support, psychedelic-assisted treatments represent a paradigm shift in mental health care. Yet the emerging ecosystem of business opportunities is highly fragmented and, with a lack of institutional capital available, Palo Santo is targeting high growth opportunities within biotech & drug development, health care services, and digital health solutions led by passionate, experienced, and ethical management teams. These businesses are positioned to have a profound impact on treating conditions such as depression, PTSD, anxiety, OCD, drug and alcohol dependence, chronic pain, Alzheimer’s, and a range of inflammatory-related illnesses.

Investments

Number of Investments
Number of Lead Investments
1
0
Palo Santo Fund has made 1 investments. Their most recent investment was on Dec 15, 2022, when Gilgamesh Pharmaceuticals raised $39M.
Date Company Name
Round Money Raised Industry Lead Investor
Series B $39M Biotechnology